Predictors for reduced flow velocity in left atrial appendage during sinus rhythm in patients with atrial

Eiji Fukuhara1, Takanao Mine2,3, Hideyuki Kishima1

  • 1Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Heart and Vessels
|September 24, 2020
PubMed

Insights

Reduced left atrial appendage flow velocity (LAAFV) during sinus rhythm (SR) in atrial fibrillation (AF) patients is predicted by elevated brain natriuretic peptide (BNP) and larger left atrial volume index (LAVI). This finding impacts anticoagulation decisions post-catheter ablation.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Echocardiography

Background:

  • Discontinuation of anticoagulation after catheter ablation (CA) for atrial fibrillation (AF) is debated.
  • Reduced left atrial appendage flow velocity (LAAFV) during AF can cause thrombus, but may also occur during sinus rhythm (SR).

Purpose of the Study:

  • To identify predictors of reduced LAAFV during SR in AF patients undergoing CA.
  • To assess the relationship between clinical factors, echocardiographic parameters, and LAAFV during SR.

Main Methods:

  • Transesophageal echocardiography (TEE) was used to measure LAAFV in 392 AF patients in SR before CA.
  • Clinical data, transthoracic echocardiography, and blood samples (including BNP) were collected.
  • Reduced LAAFV was defined as <35 cm/s.

Main Results:

  • 18% of patients (72/392) had reduced LAAFV during SR.
  • Reduced LAAFV was associated with non-paroxysmal AF, elevated BNP, heart failure, higher CHADS2/CHA2DS2-VASc scores, no beta-blockers, increased LAVI, elevated E/e', reduced LVEF, and LVH.
  • Multivariate analysis identified elevated BNP and LAVI as independent predictors of reduced LAAFV during SR.

Conclusions:

  • Elevated brain natriuretic peptide (BNP) levels and large left atrial volume index (LAVI) are significant predictors of decreased left atrial appendage flow velocity (LAAFV) during sinus rhythm (SR) in patients with atrial fibrillation (AF).
  • These findings may inform decisions regarding anticoagulation therapy post-catheter ablation.